First-in-Human Study of BGB-45035 in Healthy Adults and Autoimmune Patients
The first-in-human study of BGB-45035 will assess its safety and pharmacokinetics in healthy participants and adults with autoimmune dermatological diseases.
Indication
Clinical and regulatory intelligence for Autoimmune Diseases with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.